$BHC Q3 '26 Earnings Results & Recap
• Reported GAAP EPS of $2.52 up 56.52% YoY
• Reported revenue of $4.19B up 56.17% YoY
• Bausch Health raised FY2026 guidance: consolidated revenue of $10.98B$11.18B and Adjusted EBITDA of $4.32B$4.42B; excluding Bausch + Lomb, revenue is $5.53B$5.63B, Adjusted EBITDA $3.23B$3.28B, and adjusted cash flows $1.6B$1.68B.